Bipolar disorder

2 trials MedDRA PT
2 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

2 trials
  • Intra-Cellular Therapies Inc. Commercial
    LUMATEPERONE
    2024-513036-26-00 2 countries 2024 n=80
    Ended
  • Intra-Cellular Therapies Inc. Commercial
    LUMATEPERONE
    2024-513037-20-00 2 countries 2024 n=60
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Intra-Cellular Therapies Inc. Commercial 2 Phase III 0
New trials by year
2024
2
← All indication landscapes